ILMN
Price
$77.22
Change
-$0.13 (-0.17%)
Updated
Apr 28 closing price
Capitalization
21.09B
9 days until earnings call
NURO
Price
$4.33
Change
-$0.01 (-0.23%)
Updated
Apr 28, 02:21 PM (EDT)
Capitalization
8.07M
Ad is loading...

ILMN vs NURO

Header iconILMN vs NURO Comparison
Open Charts ILMN vs NUROBanner chart's image
Illumina
Price$77.22
Change-$0.13 (-0.17%)
Volume$1.11M
Capitalization21.09B
NeuroMetrix
Price$4.33
Change-$0.01 (-0.23%)
Volume$100
Capitalization8.07M
ILMN vs NURO Comparison Chart
Loading...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NURO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ILMN vs. NURO commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ILMN is a Buy and NURO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (ILMN: $77.22 vs. NURO: $4.36)
Brand notoriety: ILMN: Notable vs. NURO: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ILMN: 46% vs. NURO: 52%
Market capitalization -- ILMN: $21.09B vs. NURO: $8.07M
ILMN [@Medical Specialties] is valued at $21.09B. NURO’s [@Medical Specialties] market capitalization is $8.07M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ILMN’s FA Score shows that 0 FA rating(s) are green whileNURO’s FA Score has 1 green FA rating(s).

  • ILMN’s FA Score: 0 green, 5 red.
  • NURO’s FA Score: 1 green, 4 red.
According to our system of comparison, NURO is a better buy in the long-term than ILMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ILMN’s TA Score shows that 5 TA indicator(s) are bullish while NURO’s TA Score has 4 bullish TA indicator(s).

  • ILMN’s TA Score: 5 bullish, 3 bearish.
  • NURO’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both ILMN and NURO are a good buy in the short-term.

Price Growth

ILMN (@Medical Specialties) experienced а +7.25% price change this week, while NURO (@Medical Specialties) price change was +0.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +50.30%. For the same industry, the average monthly price growth was +30.67%, and the average quarterly price growth was -1.71%.

Reported Earning Dates

ILMN is expected to report earnings on Aug 07, 2025.

NURO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Medical Specialties (+50.30% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ILMN($21.1B) has a higher market cap than NURO($8.07M). NURO YTD gains are higher at: 9.320 vs. ILMN (-42.214). NURO has higher annual earnings (EBITDA): -7.1M vs. ILMN (-608M). ILMN has more cash in the bank: 1.05B vs. NURO (18M). NURO has less debt than ILMN: NURO (241K) vs ILMN (2.26B). ILMN has higher revenues than NURO: ILMN (4.5B) vs NURO (5.9M).
ILMNNUROILMN / NURO
Capitalization21.1B8.07M261,624%
EBITDA-608M-7.1M8,568%
Gain YTD-42.2149.320-453%
P/E Ratio49.50N/A-
Revenue4.5B5.9M76,326%
Total Cash1.05B18M5,856%
Total Debt2.26B241K938,589%
FUNDAMENTALS RATINGS
ILMN vs NURO: Fundamental Ratings
ILMN
NURO
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
6550
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NURO's Valuation (27) in the Medical Specialties industry is somewhat better than the same rating for ILMN (77) in the Biotechnology industry. This means that NURO’s stock grew somewhat faster than ILMN’s over the last 12 months.

NURO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ILMN (100) in the Biotechnology industry. This means that NURO’s stock grew similarly to ILMN’s over the last 12 months.

ILMN's SMR Rating (96) in the Biotechnology industry is in the same range as NURO (97) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to NURO’s over the last 12 months.

NURO's Price Growth Rating (50) in the Medical Specialties industry is in the same range as ILMN (65) in the Biotechnology industry. This means that NURO’s stock grew similarly to ILMN’s over the last 12 months.

ILMN's P/E Growth Rating (93) in the Biotechnology industry is in the same range as NURO (100) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to NURO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ILMNNURO
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 19 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 19 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
68%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 19 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 19 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 26 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 22 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
64%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 19 days ago
86%
View a ticker or compare two or three
Ad is loading...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NURO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with RVTY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
-0.17%
RVTY - ILMN
58%
Loosely correlated
+0.82%
BIO - ILMN
53%
Loosely correlated
-1.01%
A - ILMN
52%
Loosely correlated
+0.56%
BRKR - ILMN
52%
Loosely correlated
+1.51%
TMO - ILMN
50%
Loosely correlated
-0.68%
More

NURO and

Correlation & Price change

A.I.dvisor tells us that NURO and JNDOF have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NURO and JNDOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURO
1D Price
Change %
NURO100%
-0.80%
JNDOF - NURO
33%
Poorly correlated
N/A
SGHT - NURO
26%
Poorly correlated
-2.13%
RVP - NURO
23%
Poorly correlated
+0.16%
ILMN - NURO
23%
Poorly correlated
-0.34%
FLMNY - NURO
22%
Poorly correlated
N/A
More